The company whose name is synonymous with aspirin is looking for a speedy remedy for stagnant sales.
Scientists at Bayer Consumer Care headquarters in New Jersey worked for five years to address consumers' No. 1 complaint: That the aspirin doesn't work fast enough to relieve pain.
So on Monday, Bayer is introducing a reformulated aspirin that it says works in half the time of regular aspirin.
Dubbed Pro-Release Technology, it uses aspirin micro-particles about a tenth the size of those in standard Bayer in tablets that dissolve and enter the bloodstream much more quickly.
Bayer says its aspirin is now better-known for preventing heart attack and stroke than for its pain reliever roots. Bayer says it needs to revitalize the brand and target younger customers.